GSK tired of merger talk?
Executive Summary
GlaxoSmithKline CEO J.P. Garnier opted not to comment on M&A plans during a Sept. 18 Bear Stearns appearance - a rare departure for the executive who has been a vocal champion of consolidation in the industry. Asked about merger plans, Garnier answered: "You're just going to misquote me anyway, so next question"...